Related Experiment Video
Updated: May 7, 2026

Author Spotlight: Developing a Safer and More Efficient Treatment Protocol for Wasting Marmoset Syndrome (WMS)
Published on: July 12, 2024
Treatment of hypomagnesemia
1Department of Endocrinology, Queen Elizabeth Hospital, Edgbaston, Birmingham, United Kingdom.
This case highlights symptomatic hypomagnesemia caused by proton pump inhibitors (PPIs) in a patient with short bowel syndrome. Treatment involved magnesium and calcium replacement after PPI withdrawal.
Area of Science:
- Nephrology
- Gastroenterology
- Endocrinology
Background:
- Serum magnesium levels are regulated by intestinal absorption and renal excretion.
- Hypomagnesemia (low magnesium) can stem from poor intake, GI/renal losses, or intracellular shifts.
- Proton pump inhibitors (PPIs) are a known cause of drug-induced hypomagnesemia.
Observation:
- A patient with short bowel syndrome presented with symptomatic hypomagnesemia.
- Concurrent proton pump inhibitor (PPI) therapy was identified as a contributing factor.
- Investigations showed reduced 24-hour urinary magnesium excretion and secondary hypocalcemia.
Findings:
- Discontinuation of PPIs was a key step in management.
- Intravenous and oral magnesium and calcium repletion were administered.
- The case illustrates the complex management of hypomagnesemia.
Implications:
- Clinicians should consider PPIs in patients with unexplained hypomagnesemia, especially those with malabsorption syndromes.
- Monitoring magnesium levels is crucial in patients on long-term PPI therapy.
- This case underscores the importance of a comprehensive, evidence-based approach to treating electrolyte disturbances.
Related Concept Videos
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Mania and Antimanic Drugs: Overview
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Pharmaceutical Poisoning: Treatment Strategies
Acute Kidney Injury V: Interprofessional Care
Heart Failure Drugs: Inotropic Agents

